From ConMed to KYOCERA, the mid-tier orthopedic device companies generate revenue between $200 million and $500 million. In 2019, these 11 companies combined to grow 5.8% year over year.
Industry veteran Tiger Buford shares how COVID-19 has the potential to affect the work of orthopedic professionals profoundly—both in ways that work is conducted and in the end product that is created.
Materials information leads to decision making by nearly every department. Knowing how materials move through the product development process can significantly shorten time-to-market, reduce compliance risks, fine-tune manufacturing processes and improve overall device quality.
Players like Arthrex, Conformis, DePuy Synthes, Zimmer Biomet and others gained clearances in 1Q for a variety of updates and line extensions for their knee, hip and shoulder devices.
You've settled on a concept for your next orthopedic device. Great! These critical steps will assist you through your feasibility, development and commercialization actions.
Zimmer Biomet's Persona is the latest knee system to work with VERASENSE, a sensor-assisted device to measure tibial coronal alignment and quantify soft tissue balance.
Times of market uncertainty require even greater collaboration in the supply chain. The Getting to We process crafts business relationships and drives collaborative partnerships.
